A Randomized, Double-Masked, Parallel- Group, Phase 2a Dry Eye Disease Clinical Trial to Evaluate the Safety and Efficacy of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent

被引：0
|
作者：
Clark, David [1 ]
Ousler, George W. [2 ]
Hollander, David [2 ]
Brady, Todd [1 ]
机构：
[1] Aldeyra Therapeut, Clin, Lexington, MA USA
[2] Ora Inc, Andover, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1967
引用
收藏
页数：2
相关论文
共 44 条
  • [1] A Randomized, Multi-Center, Double-Masked, Vehicle-Controlled, Parallel-Group Phase 2b Allergic Conjunctivitis Clinical Trial of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent
    Gomes, Paul J.
    Brady, Todd
    Hollander, David
    Clark, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [2] A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease
    Clark, David
    Sheppard, John
    Brady, Todd C.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 37 (04) : 193 - 199
  • [3] Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled Phase 2b Dry Eye Disease Clinical Trial to Evaluate Safety and Efficacy of Topical Ocular Reproxalap, a Novel RASP Inhibitor
    Sheppard, John D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [4] Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial
    Kasetsuwan, Ngamjit
    Chantaralawan, Kanawat
    Reinprayoon, Usanee
    Uthaithammarat, Lita
    PLOS ONE, 2020, 15 (06):
  • [5] A phase 2a, double-masked, randomized, vehicle-controlled trial of VVN001 in subjects with dry eye disease
    Tauber, Joseph
    Evans, David
    Segal, Bruce
    Li, Xiao-Yan
    Shen, Wang
    Lu, Caroline
    Novack, Gary D.
    OCULAR SURFACE, 2023, 28 : 18 - 24
  • [6] Prospective, Randomized, Double-Masked Clinical Trial Comparing Safety and Efficacy of Topical Tacrolimus vs. Methylprednisolone for Ocular Graft-Versus-Host Disease
    Saboo, Ujwala Sachin
    Abud, Tulio
    Amparo, Francisco
    Ciolino, Joseph B.
    Hamrah, Pedram
    Dana, Reza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [7] A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea
    Webster, G.
    Draelos, Z. D.
    Graber, E.
    Lee, M. S.
    Dhawan, S.
    Salman, M.
    Magrath, G. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (03) : 471 - 479
  • [8] Efficacy and Safety of Useul for Dry Eye Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel, Phase 2 Clinical Trial
    Lyu, Yee-Ran
    Kwon, O-Jin
    Park, Bongkyun
    Jung, Hyun-A
    Lee, Ga-Young
    Kim, Chan-Sik
    HEALTHCARE, 2024, 12 (23)
  • [9] A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease
    Schmidl, Doreen
    Szalai, Laszlo
    Kiss, Orsolya G.
    Schmetterer, Leopold
    Garhofer, Gerhard
    ADVANCES IN THERAPY, 2021, 38 (04) : 1975 - 1986
  • [10] A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease
    Doreen Schmidl
    László Szalai
    Orsolya G. Kiss
    Leopold Schmetterer
    Gerhard Garhöfer
    Advances in Therapy, 2021, 38 : 1975 - 1986
12345